Ethenyldiphenylsulfonium | 46392-67-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: Ethenyldiphenylsulfonium
• 英文别名: ethenyl(diphenyl)sulfanium
• CAS: 46392-67-0
• 化学式: C14H13S+
• 分子量: 213.32
• InChiKey: PNSIVCZZUSGIGC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  1
• 氢给体数：
  0
• 氢受体数：
  0

文献信息

• DIHYDRO 1,4-BENZOXAZINES AND METHOD OF SYNTHESIZING THE SAME USING SULFONIUM SALTS
  申请人：COMSATS Institute of Information Technology

  公开号：US20140323720A1

  公开（公告）日：2014-10-30

  Exemplary embodiments of the present invention relate to benzoxazines having various N-protecting groups. An R 1 functional group is at least one selected from the group consisting of H and a halogen, an R 2 functional group is at least one selected from the group consisting of H, an amide, or a carbamate, and a Z functional group is at least one selected from the group consisting of a phenyl, substituted phenyl group, methyl, and t-butyl group. The exemplary embodiments provide compounds with benzoxazines having various cleavable protecting groups such as amides and carbamates.

  本发明的示范性实施例涉及具有不同N-保护基团的苯并噁嗪。R1功能基团至少选自H和卤素组成的组，R2功能基团至少选自H、酰胺或碳酸酯组成的组，Z功能基团至少选自苯基、取代苯基、甲基和叔丁基组成的组。示范性实施例提供了具有不同可裂解保护基团的苯并噁嗪化合物，如酰胺和碳酸酯。
• RESIST COMPOSITION, METHOD FOR FORMING RESIST PATTERN, ACID GENERATOR AND COMPOUND
  申请人：TOKYO OHKA KOGYO CO., LTD.

  公开号：US20160274458A1

  公开（公告）日：2016-09-22

  A resist composition which generates acid upon exposure and exhibits changed solubility in a developing solution under action of acid, and which includes a base component (A) which exhibits changed solubility in a developing solution under action of acid and an acid-generator component (B) which generates acid upon exposure, the acid-generator component (B) including a compound (B0-1) represented by general formula (b0) shown below (in the formula, Yx 01 represents a divalent linking group; n represents an integer of 1 to 3; and M′ m+ represents an organic cation having a valency of m.

  一种抗蚀组合物，暴露后产生酸并在酸的作用下在显影液中表现出改变的溶解度，其中包括一种碱性组分（A），在酸的作用下在显影液中表现出改变的溶解度，以及一种产生酸的酸发生组分（B），其中酸发生组分（B）包括一种由下式（b0）表示的化合物（B0-1）（在该式中，Yx01表示双价连接基；n表示1至3的整数；M′m+表示具有价态m的有机阳离子）。
• PYRIMIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE
  申请人：Bergeron Philippe

  公开号：US20120165313A1

  公开（公告）日：2012-06-28

  Disclosed are compounds of Formula I, including steroisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, that are useful in modulating PIKK related kinase signaling, e.g., mTOR, and for the treatment of diseases (e.g., cancer) that are mediated at least in part by the dysregulation of the PIKK signaling pathway (e.g., mTOR).

  本发明揭示了I式化合物，包括立体异构体、几何异构体、互变异构体、溶剂化物、代谢物和药学上可接受的盐，对于调节PIKK相关激酶信号传导，例如mTOR，并用于治疗通过PIKK信号通路（例如mTOR）失调至少部分介导的疾病（例如癌症）是有用的。
• [EN] TETRAHYDROISOQUINOLINE DERIVATIVE AND USE THEREOF<br/>[FR] DÉRIVÉ DE TÉTRAHYDROISOQUINOLÉINE ET SON UTILISATION<br/>[ZH] 四氢异喹啉衍生物及其应用
  申请人：MEDSHINE DISCOVERY INC

  公开号：WO2022063094A1

  公开（公告）日：2022-03-31

  一系列四氢异喹啉衍生物及其晶型，具体公开了式(VII)所示化合物、其晶型及其药学上可接受的盐。
• Fused-ring or tricyclic aryl pyrimidine compound used as kinase inhibitor
  申请人：NANJING SANHOME PHARMACEUTICAL CO., LTD

  公开号：US10093656B2

  公开（公告）日：2018-10-09

  Disclosed is a fused-ring or tricyclic aryl pyrimidine compound used as a mutation selectivity EGFR inhibitor. Specifically, disclosed is a compound represented by formula (I) and used as an EGFR inhibitor or a pharmaceutically acceptable salt thereof.

  公开了一种作为突变选择性表皮生长因子受体抑制剂的融合环或三环芳基嘧啶化合物。具体地说，公开了一种由式（I）代表并用作表皮生长因子受体抑制剂的化合物或其药学上可接受的盐。